Gene Solutions Indonesia and PDPI East Java Symposium on Advanced Lung Cancer Management and Genomic Innovations

Photo: Gene Solutions Indonesia and PDPI East Java Symposium in a group photo.
Photo: Gene Solutions Indonesia and PDPI East Java Symposium in a group photo.

Gene Solutions Indonesia, in collaboration with the Indonesian Society of Respirology (PDPI) East Java branch, hosted a mini symposium in Surabaya on August 4, 2024. The event, centred on lung cancer management, brought together leading experts to discuss cutting-edge advancements in genomic profiling and early cancer detection.

Moderated by the esteemed Dr. Daniel Maranatha, SpP(K), the symposium opened with Prof. DR. Dr. Laksmi Wulandari, SpP(K)Onk, delivering an insightful presentation on “Lung Cancer Management – The Unmet Need on Monitoring the Disease.” This was followed by Dr. Anna Febriani, SpP(K)Onk, who shared a compelling case study on “Lung Cancer Follow-up and Monitoring” highlighting real-world challenges and solutions in patient care.

Photo: Prof. DR. dr. Laksmi Wulandari, SpP(K)Onk presenting.

Photo: Prof. DR. dr. Laksmi Wulandari, SpP(K)Onk presenting. Photo: Prof. DR. dr. Laksmi Wulandari, SpP(K)Onk presenting.

Gene Solutions Indonesia was honoured by the warm reception from the attendees and took this opportunity to present on two pivotal topics: “Advanced Technology on Genomic Profiling and Monitoring the Dynamics of ctDNA” and “Multi-Cancer Early Detection in High-Risk Populations of Lung Cancer.” These presentations offered a glimpse into the future of oncology, showcasing how innovative technologies like K-TRACK and SPOT-MAS are poised to transform cancer treatment and prevention.

Through ongoing innovation, Gene Solutions remains committed to maximizing the provision of information and evaluation related to cancer care.

About Gene Solutions Indonesia:

Established in 2022, PT Gene Solutions Indonesia has been diligently advancing genetic testing and providing essential support to healthcare practitioners. We recognize the significance of Next-Generation Sequencing (NGS) in prenatal care and molecular diagnostics. Through our valued partnership with KALGen INNOLAB, we strive to make Non-Invasive Prenatal Testing (NIPT) and oncology diagnostics accessible to the Indonesian population.

LATEST News

New Study Validates Gene Solutions’ Upgraded ctDNA Workflow Behind K-TRACK and K-4CARE

New Study Validates Gene Solutions’ Upgraded ctDNA Workflow Behind K-TRACK and K-4CARE

Peer-reviewed findings published in The Journal of Liquid Biopsy, an official journal of the International Society of Liquid Biopsy (ISLB), demonstrate broader ctDNA analysis, improved recurrence prediction, and greater flexibility with or without tumor tissue. SINGAPORE, 14 October 2026 – Gene Solutions announced the publication of a new peer-reviewed study validating the upgraded ctDNA workflow behind K-TRACK, K-4CARE, and K-TRACK Blood Only. Published in The Journal of Liquid Biopsy, an official journal of the International Society of Liquid Biopsy (ISLB), the study evaluated how Gene Solutions’ new hybrid-capture sequencing workflow and VarSURE bioinformatics pipeline improve upon its previous amplicon-based ctDNA method.

Read More

Biomarker and ctDNA Testing: A Personalized Approach to Cancer Care

Cancer diagnosis often brings many questions: Which treatment is most suitable for me? Is my treatment working? Has cancer changed? Could it come back? Every person’s cancer is different. Even when two people have the same type of cancer, their tumors may have different biological features. These differences can influence how the cancer behaves and how it responds to treatment. Biomarker and circulating tumor DNA, or ctDNA, testing may help doctors better understand these differences. Together, these tests may support more personalized treatment decisions and provide additional information as the cancer changes over time. Why can the same cancer respond

Read More
Gene Solutions NIPT preterm birth prenatal health

Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data

A Gene Solutions study published in American Journal of Obstetrics & Gynecology (AJOG) Global Reports finds cell-free DNA fragmentomic patterns associated with spontaneous preterm birth, pointing to a potential path toward earlier pregnancy-risk assessment. SINGAPORE, Sept. 25, 2026 /PRNewswire/ — Gene Solutions, a global biotechnology company providing precision cell-free DNA solutions through multi-omics and artificial intelligence to improve pregnancy care, cancer detection and precision medicine, today announced the publication of a study showing the potential to assess the risk of spontaneous preterm birth from cell-free DNA fragmentomic signals already present in routine first-trimester non-invasive prenatal testing (NIPT) data. Published in AJOG Global Reports, the

Read More